Alpha Tau Medical (DRTS) Non-Current Debt (2023 - 2026)
Alpha Tau Medical (DRTS) reported Non-Current Debt of $6.4 million for Q1 2026, up 17.01% on a YoY basis from $5.5 million in Q1 2025, and up 0.8% sequentially from $6.4 million in Q4 2025.
Alpha Tau Medical (DRTS) Non-Current Debt (2023 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has 4 years of Non-Current Debt data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Debt rose 17.01% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 17.01% YoY), and the FY2025 full-year result was $6.4 million, up 14.22% from the prior year.
- Non-Current Debt grew to $6.4 million in Q1 2026, from $6.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $6.4 million in Q1 2026 to a low of $5.4 million in Q2 2024.
- A 4-year average of $5.8 million and a median of $5.6 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt retreated 0.98% in 2025 and increased 17.01% in 2026, its largest moves.
- Tracing DRTS's Non-Current Debt over 4 years: stood at $5.6 million in 2023, then declined by 0.87% to $5.6 million in 2024, then rose by 14.22% to $6.4 million in 2025, then increased by 0.8% to $6.4 million in 2026.
- Business Quant data shows DRTS's Non-Current Debt at $6.4 million in Q1 2026, $6.4 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 105.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 842.92 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | 6.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 6.35 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 5.41 Mn |
| Mar 31, 2024 | 5.53 Mn |
| Dec 31, 2023 | 5.61 Mn |